Lampertheim, Germany

Dietmar Boerner

This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1983-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dietmar Boerner. Retrieved from https://idiyas.com/inventor/dietmar-boerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dietmar Boerner: Innovator in Pharmaceutical Chemistry

Introduction

Dietmar Boerner is a notable inventor based in Lampertheim-Huttenfeld, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aziridine-2-carboxylic acid derivatives. With a total of 2 patents to his name, Boerner's inventions focus on enhancing immune system responses.

Latest Patents

Boerner's latest patents include the development of N-Substituted aziridine-2-carboxylic acid derivatives. These pharmaceutical compositions are designed to combat diseases associated with a weakening immune system. The compounds are characterized by a general formula that allows for various substitutions, making them versatile in their application. Another significant patent involves N-Substituted aziridine-2-carboxylic acid immunostimulant derivatives, which also aim to strengthen immune responses through similar mechanisms.

Career Highlights

Dietmar Boerner is associated with Boehringer Mannheim GmbH, a company known for its advancements in biotechnology and pharmaceuticals. His work has contributed to the development of new therapeutic agents that can potentially improve health outcomes for patients with compromised immune systems.

Collaborations

Some of Boerner's notable coworkers include Elmar Bosies and Wolfgang Kampe. Their collaborative efforts have likely played a role in the successful development of Boerner's innovative pharmaceutical compositions.

Conclusion

Dietmar Boerner's contributions to pharmaceutical chemistry through his patents on aziridine-2-carboxylic acid derivatives highlight his commitment to advancing medical science. His work continues to pave the way for new treatments aimed at enhancing immune function.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…